The effect of bromocriptine-rebound method on ongoing pregnancy and live birth after intracytoplasmic sperm injection cycles: a randomized clinical trial

Abstract

Materials and Methods: A total of 114 women underwent ICSI. Pregnancy outcomes and hormonal data were compared between two groups, i.e. long protocol and BRM. Ovulatory women with normal serum prolactin levels were assigned to either BRM (n = 57 cycles) or long protocol (n = 57 cycles). Both procedures were carried out in a similar way. However, a group of patients were given bromocriptine daily from the 4th day of the preceding cycle until 7 days before gonadotropin stimulation.